And if you're considering peptides or other unapproved therapies, you need to understand it
The body tissue distribution studies show a very high concentration of LC in mature spermatozoa and luminal fluid of cauda epididymis [26]
However, these peptide-based biologics are complex and costly to make, requiring specialized facilities and lengthy scale-up timelines
Testosterone is predominantly produced in the testes, whereas estrogen and progesterone are predominantly synthesized in the ovaries 74
1,2 Most adult women with polycystic ovary syndrome have multiple ovarian cysts and enlarged ovaries due to overexposure to androgens

Cassiopea Glenmark Pharmaceuticals Sources Primary Research Interviews Pharmaceutical manufacturers and drug developers Healthcare providers and endocrinologists Regulatory affairs specialists Pharmaceutical distributors and retailers Others Magazines Pharmaceutical Executive BioPharma Dive Diabetes Care Magazine Drug Discovery & Development Others Journals Pharmaceutical Executive BioPharma Dive Diabetes Care Magazine Drug Discovery & Development Others Newspapers Financial Times The Wall Street Journal Reuters Health News Bloomberg Healthcare Others Associations American Diabetes Association (ADA) European Association for the Study of Diabetes (EASD) International Diabetes Federation (IDF) Pharmaceutical Research and Manufacturers of America (PhRMA) Others Public Domain Sources World Health Organization (WHO) publications Centers for Disease Control and Prevention (CDC) reports European Medicines Agency (EMA) publications National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) Others Proprietary Elements CMI Data Analytics Tool GLP-1 Receptor Agonist Market CMI Existing Repository of Information for the Last 8 Years * Definition: Global GLP-1 receptor agonist market involves pharmaceutical products that mimic the effects of naturally occurring glucagon-like peptide-1 (GLP-1)
